ACTNCT04917796
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 16 versions: 11 with changes below, 5 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 11 words
- Primary completion date changed from estimate of Sep 24, 2026 to Oct 26, 2026
- Study completion pushed from Sep 24, 2026 to Dec 24, 2026
- Minor Primary and study completion pushed from Apr 24, 2026 to Sep 24, 2026v15
- Notable Eligibility criteria revised
- Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 250 to confirmed 255
- Site details revised at 6 of 6 sites
- Minor Primary and study completion dates: Dec 31, 2025 to Apr 24, 2026v13
- Minor Study sites revised (6)v12
Show 5 earlier versionsHide 5 earlier versions
- Minor Site contacts updated at 1 of 6 sitesv11
Notable Phase: Phase 3 to Not applicablev10 Show 6 more changesShow less
- Lead sponsor: Memorial Sloan Kettering Cancer Center to Dana-Farber Cancer Institute
- Primary and study completion dates: May 21, 2025 to Dec 31, 2025
- Study sites: 5 to 6
- Interventions: Electroacupuncture (Device), Sham Acupuncture (Device) to Electroacupuncture (Other), Sham Acupuncture (Other)
- Study description expanded, about 122 words
- Collaborators expanded, about 5 words
- Minor Site contacts updated at 5 of 5 sitesv7
- Minor Study sites revised (5)v6
- Minor Site contacts updated at 5 of 5 sitesv4
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
The study participants will include 250 cancer survivors who have completed neurotoxic agent containing chemotherapy at least three months prior and have persistent moderate to severe Chemotherapy-Induced Peripheral Neuropathy/CIPN pain randomized to one of two study arms.
The study participants will include 250 cancer survivors who have completed neurotoxic agent containing chemotherapy at least three months prior and have persistent moderate to severe Chemotherapy-Induced Peripheral Neuropathy/CIPN pain randomized to one of two study arms.
Other: Electroacupuncture, Sham Acupuncture
Sites
6 sites in 1 country